Gene therapy for antiangiogenesis

Journal of the National Cancer Institute

Volumn 93, Issue 13, 2001, Pages 965-967

  Kleinman, Hynda K ^a,c   Liau, Gene ^b  

^a Laboratory of Sensory Biology   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CANSTATIN; CHEMOKINE; CYTOKINE; ENDOSTATIN; FIBROBLAST GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE INHIBITOR; RETINA S ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER INHIBITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; EDITORIAL; GENE THERAPY; GENE TRANSFER; HUMAN; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION;

EID: 0035806482     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.13.965     Document Type: Editorial

References (21)

1. Endogenous angiogenesis inhibitors and their therapeutic implications
2. Angiogenesis in cancer and other diseases
3. Role of the tumor microenvironment in mediating response to antiangiogenic therapy
4. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
5. Vasculogenic mimicry and tumor angiogenesis
6. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
7. Genes expressed in human tumor endothelium
8. Clinical efforts to modulate new blood vessel formation in the adult; a comparison of gene therapy versus conventional approaches
9. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
10. Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice
11. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin
12. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas
13. Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth
14. Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach
15. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
16. Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors
17. Interaction of endostatin with integrins implicated in angiogenesis
18. Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NCI/endostatin domain
19. Gene therapy of human severe combined immunodeficiency (SCID)-XI disease
20. Clinical trials in coronary angiogenesis. Issues, problems, consensus: An expert panel summary
21. Therapeutic angiogenesis: A case for targeted, regulated gene delivery